首页> 外文期刊>European journal of cardio-thoracic surgery: Official journal of the European Association for Cardio-thoracic Surgery >Identification of clinical factors predicting Pleur(x)((R)) catheter removal in patients treated for malignant pleural effusion.
【24h】

Identification of clinical factors predicting Pleur(x)((R)) catheter removal in patients treated for malignant pleural effusion.

机译:鉴定可预测恶性胸腔积液患者中Pleur(x)(R)导管移除的临床因素。

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: The objective of the study was to review the clinical records of patients undergoing insertion of a Pleur(x)((R)) catheter in the management of malignant pleural effusions. In particular, clinical parameters were analyzed for their influence on catheter removeability. Methods: Between January 1998 and July 2006, 263 patients underwent insertion of 295 Pleur(x)((R)) catheters for malignant pleural effusion(s). Patients were allocated to one of four groups based upon the site of the primary tumor: group 1 (breast), group 2 (lung), group 3 (gynecologic), and group 4 (all others). A history of prior chest irradiation, cytologic analysis (positive or negative for malignant cells), and incidence of trapped lung were also studied to determine if, in addition to the primary site, these influenced the incidence of pleurodesis. Results: Overall, 58.6% of Pleur(x)((R)) catheters were removed prior to death. The incidence of spontaneous symphysis and catheter removal in groups 1 (69.6%) and 3 (72.5%) was significantly higher than in groups 2 and 4 (p<0.001). In addition, absence of a history of chest wall irradiation, cytologic positivity and a trapped lung all influenced catheter removeability to a significant degree (p<0.001). Conclusions: Pleur(x)((R)) catheters effectively relieve patients of dyspnea by evacuating the pleural space. Spontaneous pleural symphysis and catheter removal is more likely in patients with breast or gynecologic primary tumors, absence of chest wall irradiation, cytologic positivity, and complete re-expansion of the underlying lung.
机译:目的:本研究的目的是回顾治疗恶性胸腔积液的患者插入Pleur(x)(R)导管的临床记录。特别是,分析了临床参数对导管可移除性的影响。方法:在1998年1月至2006年7月之间,对263例患者进行了295例Pleur(x)(R)导管的插入,以进行恶性胸腔积液。根据原发肿瘤的部位将患者分为四组之一:第一组(乳房),第二组(肺),第三组(妇科)和第四组(所有其他)。还研究了先前的胸部放疗史,细胞学分析(恶性细胞为阳性或阴性)以及被困肺的发生率,以确定除主要部位外,这些因素是否也影响了胸膜固定术的发生率。结果:总的来说,在死亡之前,已移除58.6%的Pleur(x)(R)导管。第1组(69.6%)和第3组(72.5%)的自发性骨膜和导管移除的发生率显着高于第2和第4组(p <0.001)。此外,没有胸壁照射史,细胞学阳性和肺部受累均在很大程度上影响了导管的可移除性(p <0.001)。结论:Pleur(x)(R)导管可通过排空胸膜腔来有效缓解呼吸困难的患者。患有乳腺或妇科原发性肿瘤,无胸壁照射,细胞学阳性以及基础肺完全重新扩张的患者更容易发生自发性胸膜联合和导管移除。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号